CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease

CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease

Idiopathic multicentric Castleman disease (iMCD) is a life-threatening inflammatory disease requiring immediate intervention, for which the recommended first-line therapy is the Interleukin-6 pathway inhibitor siltuximab. Authors here show that the change in levels of the chemokine CXCL13 shortly fo...

Full description

Bibliographic Details
Main Authors:	Sheila K. Pierson, Laura Katz, Reece Williams, Melanie Mumau, Michael Gonzalez, Stacy Guzman, Ayelet Rubenstein, Ana B. Oromendia, Philip Beineke, Alexander Fosså, Frits van Rhee, David C. Fajgenbaum
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-11-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-022-34873-7

Similar Items

No evidence for active viral infection in unicentric and idiopathic multicentric Castleman disease by Viral-Track analysis
by: Ira Miller, et al.
Published: (2025-01-01)

Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease
by: Mateo Sarmiento Bustamante, et al.
Published: (2024-01-01)

The lymph node transcriptome of unicentric and idiopathic multicentric Castleman disease
by: Pedro Horna, et al.
Published: (2022-04-01)

Idiopathic Multicentric Castleman Disease Occurring Shortly after mRNA SARS-CoV-2 Vaccine
by: Christian Hoffmann, et al.
Published: (2022-10-01)

Common connective tissue disorder and anti-cytokine autoantibodies are enriched in idiopathic multicentric castleman disease patients
by: Allan Feng, et al.
Published: (2025-03-01)

Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.
by: Christopher S Nabel, et al.
Published: (2019-01-01)

Idiopathic multicentric Castleman’s disease
by: V. I. Vasilyev, et al.
Published: (2020-06-01)

Peripheral helper-T-cell-derived CXCL13 is a crucial pathogenic factor in idiopathic multicentric Castleman disease
by: Takuya Harada, et al.
Published: (2023-10-01)

P1140: TIME TO TUMOR, SYMPTOMATIC AND LABORATORY RESPONSES FOLLOWING SILTUXIMAB TREATMENT IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE
by: F. van Rhee, et al.
Published: (2022-06-01)

Idiopathic Multicentric Hyaline Vascular-Type Castleman Disease
by: Adelaide Moutinho, et al.
Published: (2021-01-01)

TAFRO Syndrome and Elusive Diagnosis of Idiopathic Multicentric Castleman Disease Treated with Empiric Anti-Interleukin-6 Therapy
by: Corinne Williams, et al.
Published: (2021-09-01)

Multicentric Castleman’s Disease, Associated with Idiopathic Thrombocytopenic Purpura
by: Ruchi Sood, et al.
Published: (2013-01-01)

Idiopathic Multicentric Castleman Disease with Cutaneous Manifestation: Case Report
by: Christoforos S. Kosmidis, et al.
Published: (2022-09-01)

Single-cell landscape of idiopathic multicentric Castleman disease in identical twins
by: Chan, Jason Yongsheng, et al.
Published: (2024)

A case of idiopathic multicentric Castleman's disease with secondary autoimmune neutropenia
by: Toshiki Morimoto, et al.
Published: (2024-01-01)

A Rare Variant of Idiopathic Multicentric Castleman Disease: TAFRO Syndrome
by: Ece Ük, et al.
Published: (2022-08-01)

Radiological and Pathological Features of Cyst Formation in Idiopathic Multicentric Castleman Disease
by: Ryota Otoshi, et al.
Published: (2023-04-01)

Idiopathic Multicentric Castleman Disease following SARS-CoV-2 Vaccination
by: Chien-Yu Ker, et al.
Published: (2023-07-01)

Idiopathic multicentric Castleman disease in children: a single-center retrospective analysis
by: Junye Du, et al.
Published: (2025-01-01)

Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report
by: Yu-han Gao, et al.
Published: (2024-03-01)

Cutaneous plasmacytosis: A rare initial presentation of idiopathic multicentric Castleman's disease
by: Yu Yamamoto, et al.
Published: (2021-05-01)

P1733: NON-HEMATOLOGICAL MALIGNANCIES IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE PATIENTS: A MATCHED COHORT ANALYSIS USING A HEALTH CLAIMS-BASED DATASET
by: S. Mukherjee, et al.
Published: (2022-06-01)

Global public awareness of Castleman disease and TAFRO syndrome between 2015 and 2021: A Google Trends analysis
by: Yoshito Nishimura, et al.
Published: (2022-08-01)

Nearly 70 years later: the continued unraveling of Castleman disease
by: Frits van Rhee
Published: (2022-04-01)

Internal Psychometric Validation of an International Burden of Illness Survey for Idiopathic Multicentric Castleman Disease
by: Matthew Franklin, et al.
Published: (2024-07-01)

Systemic lupus erythematosus mimicking idiopathic multicentric Castleman disease: A diagnostic dilemma
by: KUIS Gunathilake, et al.
Published: (2022-06-01)

The clinical, laboratory, and radiologic improvement due to siltuximab treatment in idiopathic multicentric Castleman’s disease
by: Gi-June Min, et al.
Published: (2021-03-01)

TAFRO Syndrome Without Pathology Supporting Castleman Disease: To Be Treated as Idiopathic Multicentric Castleman Disease-TAFRO or a Distinct Disease Entity?
by: Siyuan Li, et al.
Published: (2025-03-01)

HIV-associated multicentric Castleman’s disease
by: Wilson Josè Couto, et al.
Published: (2012-06-01)

Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas
by: Alexandra Nagy, et al.
Published: (2018-03-01)

Dichotomic response to interleukin-6 blockade in idiopathic multicentric Castleman disease: two case reports
by: Simone Ferrero, et al.
Published: (2021-03-01)

Siltuximab-Related Favorable Clinical Outcome for a Patient Suffering from Idiopathic Multicentric Castleman Disease
by: Stamatios Chrysochoou, et al.
Published: (2022-01-01)

An unusual case of HHV-8 negative, idiopathic, multicentric Castleman disease following chronic lymphocytic leukaemia
by: Pierre-Yves Sansen, et al.
Published: (2024-08-01)

Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiences
by: Bernardo Rossini, et al.
Published: (2024-03-01)

A challenging diagnosis of idiopathic multicentric Castleman disease with complex systemic presentation: A case report
by: Magdalena Strach, et al.
Published: (2023-10-01)

A case of acute progressive diffuse interstitial lung disease preceding idiopathic multicentric Castleman disease
by: Daijiro Nabeya, et al.
Published: (2020-01-01)

A Rare Association between Idiopathic Multicentric Castleman Disease, Nephrotic Syndrome and Polyneuropathy in an immunocompetent patient
by: Luís Landeiro, et al.
Published: (2021-10-01)

Multicentric Castleman's Disease (CD) in juvenile idiopathic arthritis (JIA) treated with etanercept: coincidence or causal relationship?
by: Rossi L, et al.
Published: (2008-09-01)

Multicentric Castleman's disease presenting with cutaneous plasmacytosis
by: Pawit Phadungsaksawasdi, et al.
Published: (2020-08-01)

Multicentric Castleman's disease: Report of three cases
by: M. Guazzaroni, MD PhD, et al.
Published: (2019-03-01)